[1] |
Huang Misun, Wu Yaning, Li Guilian, Liu Haican.
Research advances of Mycobacterium tuberculosis enrichment technology
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 369-373.
|
[2] |
Zhang Han, Wang Lixia, Wei Yushi, Zhao Rui, Wang Xinqi, Liu Nianqiang, Wang Senlu.
Evaluation of the application effect of digital therapeutics adherence technology in medication management of tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2024, 46(2): 158-164.
|
[3] |
SU Dan, CHE Nan-ying, OU Xi-chao, ZHAO Ying-li, LI Kun, CHEN Xue-jing, LIN Hai-feng, MU Jing, HUANG Hai-rong.
Study on the diagnostic efficacy of different bacteriological and pathological examination techniques for osteoarticular tuberculosis
[J]. Chinese Journal of Antituberculosis, 2022, 44(4): 362-367.
|
[4] |
YI Jun-li, YANG Xin-yu, CHEN Hao, ZHAO Yan-feng, CHEN Shuang-shuang, ZHANG Jie, DING Bei-chuan, DAI Xiao-wei, SUN Shan-hua, WU Wen-qing, LI Chuan-you.
Analysis of drug resistance of 1156 clinical isolates of Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(7): 677-681.
|
[5] |
ZHANG Kai-yi, LYU Zheng-xuan, LIU Yong-li, ZHANG Le, ZHU Jiang-chun, YU Ming-li.
A case of multisystemic disseminated infection caused by Mycobacterium abscess diagnostic and treatment process analysis
[J]. Chinese Journal of Antituberculosis, 2021, 43(1): 66-71.
|
[6] |
Beijing Chest Hospital, Capital Medical University, Non-tuberculous Mycobacterial Branch of the Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis .
Expert consensus on off-label use of drugs for non-tuberculous mycobacteria
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 769-787.
|
[7] |
ZHONG Qian-hong, MA Xiao-hui, LIN Zhi-hao, LI Yi, ZHOU Jie, DENG Dong-hua, DENG Ci-xi, LIANG Xiao-min.
Evaluation of the application of Foshan Tuberculosis Surveillance and Management Platform in tuberculosis prevention and treatment
[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 653-656.
|
[8] |
BAO Xun-di, JIANG Yue, LIANG Suo, CHENG Hong-yan, XIA Guang-xiu, WANG Chao, YE Qian, WANG Shu, WANG Qing.
Analysis of the clinical isolation rate, population distribution and drug resistance of non-tuberculous mycobacteria in Anhui
[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 718-724.
|
[9] |
LIU Xin, WANG Zhi-chao.
Clinical analysis of delayed diagnosis of 5 cases of tuberculous perianal abscess
[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 527-528.
|
[10] |
ZHANG Sheng-kang, TONG Zhao-wei, TANG Han-mei, YAN Mi, YUAN Dan, TANG Xi-liang, SHEN Sheng-rong.
Must value nutritional treatment of tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1272-1275.
|
[11] |
YANG Han, LI Ai-fang, WANG Pei, DANG Li-yun.
Value of DNA real-time fluorescence isothermal amplification method in clinical detection of tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1294-1298.
|
[12] |
JIANG Xiao-ying,SONG Yan-hua,WANG Yu-ying,LIU Zhi,MI Feng-ling,LIANG Jian-qin.
Quality of life assessment and risk factors analysis of 270 pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2020, 42(1): 66-73.
|
[13] |
Jia-wen WANG,Shan-shan HUANG,Kai-yi LIU,Hong-di LIANG,Hui-ying FENG,Fang-jing ZHOU,An-qi LIANG,Liang CHEN,Lin ZHOU.
The effectiveness evaluation of using mobile communication for directly observed short course chemotherapy on tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2019, 41(9): 946-950.
|
[14] |
Xue LI,Shi-wen JIANG,Dong-mei HU,Cai-hong XU,Xiao-qiu LIU.
The application of electronic medicine box and mobile phone WeChat APP on the effect of drug compliance in tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2019, 41(9): 957-961.
|
[15] |
Jia-wen LIU,Hong-yan LYU,Bei-chuan DING,Zhi-guo ZHANG.
Analysis on identification of 129 non-tuberculosis mycobacteria strains using two molecular biology techniques
[J]. Chinese Journal of Antituberculosis, 2019, 41(9): 999-1003.
|